期刊
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION
卷 2, 期 4, 页码 210-226出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jash.2008.02.001
关键词
Natriuretic peptide receptors; gene targeting; cardiovascular events; intracellular signaling
资金
- National Institutes of Health [HL57531, HL62147]
Thus far, three related natriuretic peptides (NPs) and three distinct receptors have been identified, which have advanced our knowledge towards understanding the control of high blood pressure, hypertension, and cardiovascular disorders to a great extent. Biochemical and molecular studies have been advanced to examine receptor function and signaling mechanisms and the role of second messenger cyclic guanosine monophosphate in pathophysiology of hypertension, renal hemodynamics, and cardiovascular functions. The development of gene-knockout and gene-duplication mouse models along with transgenic mice have provided a framework for understanding the importance of the antagonistic actions of NP receptors in cardiovascular events at the molecular level. Now, NPs are considered as circulating markers of congestive heart failure, however, their therapeutic potential for the treatment of cardiovascular diseases such as hypertension, renal insufficiency, cardiac hypertrophy, congestive heart failure, and stroke has just begun to unfold. Indeed, alternative avenues of investigations in this important area need to be undertaken, as we are at the initial stage of the molecular therapeutic and pharmacogenomic implications. J Am Soc Hypertens 2008;2(4): 210-226. (C) 2008 American Society of Hypertension. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据